Chemours price to free cash flow CC

Market value divided by free cash flow over the last twelve months, since 2016.

Today, Oct 23, 2026: n/m; not a meaningful number
Last meaningful: 30.4×; Oct 2023
10-year median: 10.6×
10-year range: 6.3× to 78.8×
Peer median: 26.7×

Chemours' price to free cash flow is not a meaningful number today: free cash flow over the last twelve months was zero, negative or not reported.

It was last meaningful in Oct 2023, at 30.4×.

On the days it had one over the last ten years, its median was 10.6×, from 6.3× in Sep 2021 to 78.8× in Nov 2019.

Price to free cash flow over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2023	30.4×	9.4×	47.9×
2022	9.5×	6.9×	14.9×
2021	7.7×	6.3×	10.7×
2020	7.5×	6.4×	18.9×
2019	78.8×	6.5×	78.8×
2018	7.0×	6.6×	41.6×
2017	36.1×	14.8×	38.4×
2016	15.2×	14.3×	22.5×

Against its peers

Companies in Chemicals nearest Chemours' size, closest first, today.

Company	Price to free cash flow
CCChemours	n/m
ROGRogers	27.0×
NGVTIngevity	15.5×
IOSPInnospec	34.7×
FULFuller H B	26.7×
WDFCWD 40	35.9×
CRONCronos	24.8×
AVNTAvient	19.7×
CBTCabot	13.6×
FTKFlotek Industries	n/m
CSWCSW Industrials	33.4×
Peer median	26.7×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Chemours

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.